News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,592 Results
Type
Article (1923)
Company Profile (3)
Press Release (68666)
Section
Business (21481)
Career Advice (9)
Deals (4557)
Drug Development (8163)
FDA (1804)
Job Trends (801)
News (37051)
Policy (3569)
Tag
Academia (93)
Allergies (6)
Alliances (8167)
ALS (7)
Alzheimer's disease (129)
Antibody-drug conjugate (ADC) (18)
Approvals (1839)
Artificial intelligence (17)
Automation (1)
Bankruptcy (9)
Best Places to Work (585)
Biosimilars (31)
Biotechnology (5)
Bladder cancer (15)
Brain cancer (2)
Breast cancer (29)
Cancer (289)
Cardiovascular disease (6)
Career advice (9)
CAR-T (5)
Cell therapy (30)
Clinical research (7130)
Collaboration (128)
Compensation (13)
Complete response letters (2)
COVID-19 (193)
C-suite (25)
Cystic fibrosis (4)
Data (289)
Depression (4)
Diabetes (20)
Diagnostics (638)
Digital health (1)
Drug discovery (16)
Duchenne muscular dystrophy (17)
Earnings (7719)
Events (7114)
Executive appointments (53)
FDA (1998)
Fibrodysplasia Ossificans Progressiva (1)
Funding (81)
Gene editing (3)
Gene therapy (21)
GLP-1 (51)
Government (233)
Grass and pollen (1)
Guidances (17)
Healthcare (1077)
Huntington's disease (1)
IgA nephropathy (8)
Immunology and inflammation (2)
Indications (5)
Infectious disease (200)
Inflammatory bowel disease (18)
Influenza (7)
Intellectual property (19)
IPO (1634)
Job creations (241)
Job search strategy (9)
Layoffs (7)
Legal (953)
Liver cancer (17)
Lung cancer (51)
Lymphoma (18)
Manufacturing (36)
MASH (8)
Medical device (1127)
Medtech (1128)
Mergers & acquisitions (3037)
Metabolic disorders (49)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (191)
NextGen: Class of 2025 (220)
Non-profit (62)
Obesity (19)
Opinion (1)
Ovarian cancer (14)
Pain (5)
Pancreatic cancer (9)
Parkinson's disease (21)
Partnered (2)
Patents (28)
Patient recruitment (13)
People (4997)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1934)
Phase II (2999)
Phase III (2693)
Pipeline (176)
Postmarket research (241)
Preclinical (674)
Press Release (2)
Prostate cancer (8)
Radiopharmaceuticals (22)
Rare diseases (33)
Real estate (600)
Regulatory (2645)
Reports (6)
Research institute (93)
RNA editing (1)
Schizophrenia (10)
Series A (18)
Series B (11)
Service/supplier (1)
Sickle cell disease (2)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (8)
Vaccines (26)
Venture capital (2)
Weight loss (2)
Women's health (1)
Date
Last 7 days (30)
Last 30 days (165)
Last 365 days (2729)
2025 (1445)
2024 (3257)
2023 (3836)
2022 (7033)
2021 (6386)
2020 (5875)
2019 (3863)
2018 (3010)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (81)
Alabama (3)
Arizona (9)
Asia (21553)
Australia (2436)
California (427)
Canada (263)
China (222)
Colorado (4)
Connecticut (17)
Delaware (4)
Europe (12663)
Florida (38)
Georgia (9)
Illinois (22)
India (11)
Indiana (6)
Japan (117)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (83)
Massachusetts (297)
Michigan (3)
Minnesota (29)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (248)
New York (176)
North Carolina (66)
Northern California (162)
Ohio (3)
Oregon (1)
Pennsylvania (71)
South America (107)
Southern California (198)
Tennessee (1)
Texas (38)
United States (1612)
Utah (13)
Virginia (32)
Washington D.C. (3)
Washington State (19)
Wisconsin (6)
70,592 Results for "lumiradx ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care
July 29, 2024
·
4 min read
Genetown
LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
LumiraDx Limited announced that it signed a commercial distribution agreement with Axon Lab AG for the commercialization of its LumiraDx Platform and diagnostic tests to include exclusive distribution rights in Switzerland and additional non-exclusive distribution rights in further European countries to include and starting in Germany.
July 31, 2023
·
6 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Genetown
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
LumiraDx Limited, a next generation point of care diagnostics company, announced the appointment of joint administrators for two of its subsidiaries.
December 29, 2023
·
5 min read
Policy
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
LumiraDx Limited announced that it has received notification from The Nasdaq Stock Market LLC that its securities will be suspended from trading at the open of business on January 9, 2024 as a result of the Company’s failure to maintain compliance with Nasdaq’s continued listing standards.
January 5, 2024
·
2 min read
Business
LumiraDx Reports Second Quarter 2023 Results
LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023.
August 24, 2023
·
15 min read
LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
LumiraDx Limited (Nasdaq: LMDX) today announced that it has received validation for use by the MHRA under the CTDA process for the LumiraDx SARS-CoV-2 Ag Ultra and LumiraDx SARS-CoV2 Ag & RSV tests.
June 20, 2023
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
June 23, 2025
·
1 min read
Press Releases
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025
June 12, 2025
·
6 min read
1 of 7,060
Next
